临床特征对胃癌患者发生胃周软组织转移及其生存期的影响

Abstract
Figure/Table
References (19)
Related Citation (15)

Download: PDF (553 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of clinical characteristics on patients with gastric cancer developed perigastric soft tissue metastasis and its survival time. Methods The clinical data of 412 patients with radical resection of gastric cancer admitted to Dalian Third People′s Hospital from January 2015 to June 2020 were retroreviewed, and divided into the metastasis group (134 cases) and the untransferred group (278 cases) according to whether perigastric soft tissue metastasis was combined. The effect of different clinical characteristics on the development of perigastric soft tissue metastasis in gastric cancer patients, and the impact of different clinical characteristics on the survival of patients with gastric cancer and perigastric soft tissue metastasis were observed. Results The tumor site, tumor size,depth of infiltration, lymph node metastasis, presence of distant metastasis, Bomnann typing, differentiation, serum carcinoem bryonic antigen (CEA) level were related with gastric soft tissue metastasis (P＜0.05). The tumor diameter,organ invasion, lymph node metastasis, combination of distant metastasis, serum CEA level, Borrmann classification and differentiation affected the survival of patients with gastric cancer and gastric soft tissue metastasis (P ＜0.05).Conclusion Soft tissue metastasis of gastric cancer often occurs in patients with ≥5 cm tumor diameter, infiltration depth of T4, with distant metastasis, lymph node metastasis degree＞20%, low or undifferentiated carcinoma, Borrmann infiltration type, serum CEA＞5 g/L, and poor prognosis in patients with perigastric soft tissue metastasis.

Key words： Stomach neoplasms Neoplasm metastasis Pathology Clinical Prognosis

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHAO Hongsheng
	PAN Jiyong
	YAN Ruifeng
	YAN Longchao
	CHEN Zhengda
	SONG Xiaohai
	WANG Mei▲

Cite this article:

ZHAO Hongsheng,PAN Jiyong,YAN Ruifeng, et al. Effect of clinical characteristics on patients with gastric cancer developed perigastric soft tissue metastasis and its survival time[J]. 中国当代医药, 2022, 29(2): 20-23.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2022/V29/I2/20

[15]	王静远，王小娟，章程，等.腹腔微环境与胃癌腹膜转移关系的研究进展[J].中华消化外科杂志，2020，19（9）：1004-1008.
[17]	聂毅，张悦，解荣，等.转录因子激活增强子结合蛋白4对胃癌细胞迁移和侵袭调控作用的实验研究[J].中华实验外科杂志，2021，38（1）：71-73.
[1]	张维汉，胡建昆.胃癌腹膜转移诊治现状[J].中华胃肠外科杂志，2021，24（3）：204-207.
[3]	薛侃，李子禹.胃癌腹膜转移的外科诊治观[J].中国肿瘤临床，2020，47（3）：114-117.
[4]	林晨，张再重，王烈.美国国家综合癌症网络临床实践指南：胃癌（2020V2）更新要点和解读[J].临床外科杂志，2021，29（1）：23-25.
[5]	陈银.胃癌患者临床病理因素评估胃癌淋巴结转移的预测能力分析[J].实用癌症杂志，2021，36（7）：1164-1166.
[7]	张鹏，徐岩，郭江宁，等.国际抗癌联盟-美国癌症联合委员会第7 版与第6 版TNM 分期中的pT 分期对胃癌患者预后的预测价值[J].中华肿瘤杂志，2015，37（3）：190-194.
[2]	Tonouchi A，Sugano M，Tokunaga M，et al.Extra-perigastric Extranodal Metastasis is a Significant Prognostic Factor in Node-Positive Gastric Cancer[J].World J Surg，2019，43（10）：2499-2505.
[8]	魏晟宏，王益，叶再生，等.进展期胃癌伴腹主动脉旁淋巴结转移综合治疗的研究[J].中华普通外科杂志，2021，36（4）：244-248.
[10]	陈炳合，吴新军，李帅超，等.环状RNA cRAPGEF5 对胃癌细胞增殖、侵袭和转移影响的实验研究[J].中华实验外科杂志，2021，38（1）：74-76.
[11]	徐赟.ICAM-1、LFA-1 在正常胃黏膜中及胃癌组织中的表达及意义[J].实用癌症杂志，2020，35（2）：175-177.
[12]	胡建昆，张维汉.系膜解剖理论指导下胃癌根治手术的幽门下区域淋巴结清扫[J].中华胃肠外科杂志，2019，22（5）：413-417.
[6]	Japanese Gastric Cancer Association.Japanese gastric cancer treatment guidelines 2010（ver.3）[J].Gastric Cancer，2011，14（2）：113-123.
[9]	Nakamura R，Omori T，Mayanagi S，et al.Risk of lymph node metastasis in undifferentiated-type mucosal gastric carcinoma[J].World J Surg Oncol，2019，17（1）：32.
[13]	Natsume M，Shimura T，Iwasaki H，et al.Omental adipocytes promote peritoneal metastasis of gastric cancer through the CXCL2-VEGFA axis[J].Br J Cancer，2020，123（3）：459-470.
[14]	Kanda M，Shimizu D，Sawaki K，et al.Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer[J].Mol Cancer，2020，19（1）：131.
[16]	Daryabari SS，Fathi M，Mahdavi M，et al.Overexpression of CFL1 in gastric cancer and the effects of its silencing by siRNA with a nanoparticle delivery system in the gastric cancer cell line[J].J Cell Physiol，2020，235（10）：6660-6672.
[18]	Zhang N，Deng J，Sun W，et al.Extranodal soft tissue metastasis as an independent prognostic factor in gastric cancer patients aged under 70 years after curative gastrectomy[J].Ann Transl Med，2020，8（6）：376.
[19]	Tauziède-Espariat A，Couvelard A，Raffoul J，et al.Gastric metastasis of merkel cell carcinoma：Review of the literature and histopathological differential diagnoses[J].Ann Pathol，2020，40（4）：300-305.